Annual Shareholders Equity
-$18.61 M
-$97.35 M-123.63%
December 31, 2022
Summary
- As of February 23, 2025, SRNE annual stockholders equity is -$18.61 million, with the most recent change of -$97.35 million (-123.63%) on December 31, 2022.
- During the last 3 years, SRNE annual shareholders equity has fallen by -$97.19 million (-123.67%).
- SRNE annual shareholders equity is now -108.88% below its all-time high of $209.47 million, reached on December 31, 2018.
Performance
SRNE Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
-$205.11 M
-$79.61 M-63.44%
June 30, 2023
Summary
- As of February 23, 2025, SRNE quarterly stockholders equity is -$205.11 million, with the most recent change of -$79.61 million (-63.44%) on June 30, 2023.
- Over the past year, SRNE quarterly shareholders equity has dropped by -$79.61 million (-63.44%).
- SRNE quarterly shareholders equity is now -180.64% below its all-time high of $254.37 million, reached on June 30, 2018.
Performance
SRNE Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
SRNE Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -123.6% | -63.4% |
| 3 y3 years | -123.7% | -63.4% |
| 5 y5 years | -109.3% | -63.4% |
SRNE Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -123.6% | at low | -190.5% | at low |
| 5 y | 5-year | -111.3% | at low | -188.6% | at low |
| alltime | all time | -108.9% | at low | -180.6% | at low |
Sorrento Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | -$205.11 M(+63.4%) |
| Mar 2023 | - | -$125.50 M(+574.5%) |
| Dec 2022 | -$18.61 M(-123.6%) | -$18.61 M(-114.1%) |
| Sep 2022 | - | $131.85 M(-0.1%) |
| Jun 2022 | - | $132.02 M(-41.7%) |
| Mar 2022 | - | $226.54 M(+187.7%) |
| Dec 2021 | $78.75 M(-52.3%) | $78.75 M(-40.1%) |
| Sep 2021 | - | $131.50 M(-29.4%) |
| Jun 2021 | - | $186.17 M(-19.6%) |
| Mar 2021 | - | $231.44 M(+40.1%) |
| Dec 2020 | $165.15 M(+110.1%) | $165.15 M(-19.6%) |
| Sep 2020 | - | $205.44 M(+49.6%) |
| Jun 2020 | - | $137.28 M(+35.9%) |
| Mar 2020 | - | $101.04 M(+28.6%) |
| Dec 2019 | $78.59 M(-62.5%) | $78.59 M(+71.2%) |
| Sep 2019 | - | $45.90 M(-45.1%) |
| Jun 2019 | - | $83.53 M(-36.7%) |
| Mar 2019 | - | $131.94 M(-37.0%) |
| Dec 2018 | $209.47 M(+5.0%) | $209.47 M(-5.5%) |
| Sep 2018 | - | $221.59 M(-12.9%) |
| Jun 2018 | - | $254.37 M(+8.3%) |
| Mar 2018 | - | $234.81 M(+17.7%) |
| Dec 2017 | $199.57 M(+149.3%) | $199.57 M(+52.3%) |
| Sep 2017 | - | $131.02 M(+41.8%) |
| Jun 2017 | - | $92.42 M(+60.0%) |
| Mar 2017 | - | $57.78 M(-27.8%) |
| Dec 2016 | $80.04 M(-44.9%) | $80.04 M(+0.5%) |
| Sep 2016 | - | $79.66 M(-44.0%) |
| Jun 2016 | - | $142.24 M(+50.0%) |
| Mar 2016 | - | $94.81 M(-34.7%) |
| Dec 2015 | $145.15 M(+33.5%) | $145.15 M(-0.7%) |
| Sep 2015 | - | $146.19 M(+60.2%) |
| Jun 2015 | - | $91.25 M(-8.7%) |
| Mar 2015 | - | $100.00 M(-8.0%) |
| Dec 2014 | $108.71 M(+62.7%) | $108.71 M(+53.1%) |
| Sep 2014 | - | $70.99 M(-9.0%) |
| Jun 2014 | - | $78.02 M(+31.9%) |
| Mar 2014 | - | $59.15 M(-11.5%) |
| Dec 2013 | $66.81 M | $66.81 M(+116.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2013 | - | $30.88 M(+435.2%) |
| Jun 2013 | - | $5.77 M(-44.1%) |
| Mar 2013 | - | $10.32 M(+66.6%) |
| Dec 2012 | $6.20 M(+47.2%) | $6.20 M(-15.7%) |
| Sep 2012 | - | $7.35 M(-13.6%) |
| Jun 2012 | - | $8.50 M(+149.7%) |
| Mar 2012 | - | $3.40 M(-19.1%) |
| Dec 2011 | $4.21 M(-17.2%) | $4.21 M(+48.3%) |
| Sep 2011 | - | $2.84 M(-18.2%) |
| Jun 2011 | - | $3.47 M(-22.5%) |
| Mar 2011 | - | $4.48 M(-12.0%) |
| Dec 2010 | $5.08 M(+58.8%) | $5.08 M(+191.2%) |
| Sep 2010 | - | $1.75 M(-18.5%) |
| Jun 2010 | - | $2.14 M(-19.3%) |
| Mar 2010 | - | $2.65 M(-17.1%) |
| Dec 2009 | $3.20 M(-2826.3%) | $3.20 M(-16.6%) |
| Sep 2009 | - | $3.84 M(+1410.5%) |
| Jun 2009 | - | $254.20 K(-23.8%) |
| Mar 2009 | - | $333.70 K(-384.2%) |
| Dec 2008 | -$117.40 K(-731.2%) | -$117.40 K(-126.8%) |
| Sep 2008 | - | $437.30 K(>+9900.0%) |
| Jun 2008 | - | $0.00(-100.0%) |
| Mar 2008 | - | $5400.00(-71.0%) |
| Dec 2007 | $18.60 K(-103.9%) | $18.60 K(-28.5%) |
| Sep 2007 | - | $26.00 K(-29.2%) |
| Jun 2007 | - | $36.70 K(-25.6%) |
| Mar 2007 | - | $49.30 K(-110.4%) |
| Dec 2006 | -$471.80 K(+1351.7%) | -$471.80 K(+1351.7%) |
| Sep 2006 | - | -$32.50 K(0.0%) |
| Jun 2006 | - | -$32.50 K(0.0%) |
| Mar 2006 | - | -$32.50 K(0.0%) |
| Dec 2005 | -$32.50 K(-90.5%) | -$32.50 K(-90.5%) |
| Sep 2005 | - | -$341.10 K(+0.1%) |
| Jun 2005 | - | -$340.90 K(+0.1%) |
| Mar 2005 | - | -$340.70 K(+0.1%) |
| Dec 2004 | -$340.50 K(+0.2%) | -$340.50 K(+0.1%) |
| Sep 2004 | - | -$340.30 K(+0.0%) |
| Jun 2004 | - | -$340.20 K(+0.1%) |
| Mar 2004 | - | -$340.00 K |
| Dec 2003 | -$339.80 K | - |
FAQ
- What is Sorrento Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Sorrento Therapeutics?
- What is Sorrento Therapeutics annual shareholders equity year-on-year change?
- What is Sorrento Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Sorrento Therapeutics?
- What is Sorrento Therapeutics quarterly shareholders equity year-on-year change?
What is Sorrento Therapeutics annual stockholders equity?
The current annual shareholders equity of SRNE is -$18.61 M
What is the all time high annual shareholders equity for Sorrento Therapeutics?
Sorrento Therapeutics all-time high annual stockholders equity is $209.47 M
What is Sorrento Therapeutics annual shareholders equity year-on-year change?
Over the past year, SRNE annual stockholders equity has changed by -$97.35 M (-123.63%)
What is Sorrento Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of SRNE is -$205.11 M
What is the all time high quarterly shareholders equity for Sorrento Therapeutics?
Sorrento Therapeutics all-time high quarterly stockholders equity is $254.37 M
What is Sorrento Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, SRNE quarterly stockholders equity has changed by -$79.61 M (-63.44%)